Skip to content
drillr.ai

IRIX

IRIDEX Corporation

NASDAQ · USHealthcareMedical - Devices
$0.93-0.94%

Price as of Jul 20, 2026

IRIX news

IRIDEX Corporation news

A server-rendered, paginated timeline of the latest available company news.

  1. Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

    MOUNTAIN VIEW, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced plans to participate in the upcoming Planet MicroCap Las Vegas 2026 Conference. Management is scheduled to present on Wednesday, June 17 at 4:00 pm PT. Interested parties may access a live and archived webcast of the

    Globe Newswire ·

  2. Iridex Reports First Quarter 2026 Financial Results

    MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the first quarter ended April 4, 2026. First Quarter 2026 Financial Highlights * Generated total revenue of $11.8 million, compared to $11.9 million in the prior year period * Cyclo G6® product fam

    Globe Newswire ·

  3. Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

    MOUNTAIN VIEW, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the fourth quarter and full year ended January 3, 2026. Fourth Quarter 2025 Financial Highlights * Generated total revenue of $14.7 million, representing growth of 16% year-over-year compared to $

    Globe Newswire ·

  4. Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026

    MOUNTAIN VIEW, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the fourth quarter and full year 2025 and provide a business update after the close of trading on March 26, 2026. The Company’s management team will host a corresponding conferen

    Globe Newswire ·